|
Symbol
|
RMBQ5V | KZEHDU | KZJVDU | RMBAIV | RMAXAV | Z0AXYZ | LAAHDU | Z0B18Z | RMA09V | RMBX5V | ACMVSQ | ADAATQ | ADKOTQ | RMAY9V | RMBACV | ADXETQ | DAGBKB | LAUJDU | 1129BC | AEEBTQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Callable Multi Defender Vonti | Autocallable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible |
|
Basiswert
|
Eli Lilly & Co. / Novo Nordisk AS (B) / Roche PS / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) / Ypsomed Hldg. AG | Novo Nordisk AS (B) / Roche PS / Sandoz Group AG / Ypsomed Hldg. AG | ASML Hldg. N.V. / LVMH Moet Hennessy Louis Vuitton / Novo Nordisk AS (B) | Novo Nordisk AS (B) / Roche PS | Amazon.com Inc. / Novo Nordisk AS (B) / UBS Group AG | Novo Nordisk AS (B) / Philips Electronics N.V. / Roche PS / Siemens Healthineers | Novo Nordisk AS (B) / SAP SE | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Lonza Group N / Novo Nordisk AS (B) | Lonza Group N / Novo Nordisk AS (B) / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) / Ypsomed Hldg. AG | Novartis AG / Novo Nordisk AS (B) / Roche PS / Sanofi S.A. | Eli Lilly & Co. / Novartis AG / Novo Nordisk AS (B) / Roche PS | Bayer AG / Novo Nordisk AS (B) / Sanofi S.A. | Eli Lilly & Co. / Novartis AG / Novo Nordisk AS (B) / Roche PS | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) |
|
Emittent
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fälligkeit
|
17.11.2026 | 20.11.2026 | 30.12.2026 | 30.12.2026 | 12.10.2026 | 16.10.2026 | 28.10.2026 | 29.10.2026 | 12.05.2027 | 16.11.2026 | 23.11.2026 | 27.11.2026 | 08.10.2026 | 14.01.2027 | 25.01.2027 | 12.02.2027 | 12.02.2027 | 01.03.2027 | 05.03.2027 | 08.12.2026 |
| Geld | 33.900 | 33.550 | 31.700 | 42.300 | 59.50 | - | 59.40 | - | 58.90 | 57.30 | 61.03 | 57.89 | 57.67 | 58.50 | 84.40 | 98.51 | 101.06 | 93.60 | 86.95 | 92.77 |
| Brief | - | 34.550 | - | - | - | - | 60.40 | - | - | - | - | - | - | - | - | 99.31 | 101.87 | 94.60 | 87.64 | - |